We are live on ! Find out more
CPHI icon

China Pharma Holdings
CPHI

6 hedge funds and large institutions have $1.04M invested in China Pharma Holdings in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 6 → 6 (0)

0% less ownership

Funds ownership: 0.02% → 0.01% (-0%)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

7% less capital invested

Capital invested by funds: $1.13M → $1.04M (-$83K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.62K
2
Citigroup
Citigroup
New York
+$518

Top Sellers

1
FWSM
First Wilshire Securities Management
California
-$231K
2
VKH
Virtu KCG Holdings
New York
-$6K
3
UBS Group
UBS Group
Switzerland
-$2K
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.55K
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
1
Pope Asset Management
Tennessee
$716K – – –
FWSM
2
First Wilshire Securities Management
California
$211K -$231K -1,339 -52%
GA
3
Glenhill Advisors
New York
$68K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$45K -$1.55K -9 -3%
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$4K +$3.62K +21 New
Citigroup
6
Citigroup
New York
$1K +$518 +3 New
VKH
7
Virtu KCG Holdings
New York
– -$6K -40 Closed
UBS Group
8
UBS Group
Switzerland
– -$2K -11 Closed

CPHI Hedge Fund Activity: Q1 2015 in Review

6 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q1 2015, worth a combined $1.04M — down 7.4% from $1.13M a quarter earlier.

Fund positioning in CPHI was balanced in Q1 2015: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 2 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $3.62K. The largest seller was First Wilshire Securities Management, cutting an estimated $231K.

  • 6 institutional investors held China Pharma Holdings (CPHI) as of Q1 2015, unchanged from Q4 2014.
  • Funds reported $1.04M of China Pharma Holdings stock for Q1 2015, down 7.4% quarter-over-quarter.
  • 2 funds opened new China Pharma Holdings positions in Q1 2015 and 2 closed out, a net change of 0 holders.
  • The largest China Pharma Holdings buyer in Q1 2015 was Susquehanna International Group, an estimated $3.62K added.
  • The largest China Pharma Holdings seller in Q1 2015 was First Wilshire Securities Management, an estimated $231K sold.

Based on aggregated 13F filings for Q1 2015.